BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36193311)

  • 1. Prognostic Index for Nonsmall Cell Lung Cancer Based on Immune-Related Genes Expression.
    Cao Y; Zhu H; Shen H; Liu D; Li Z; Shang H; Du H; Wang Y; Ye J
    Biomed Res Int; 2022; 2022():4779811. PubMed ID: 36193311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A robust signature associated with patient prognosis and tumor immune microenvironment based on immune-related genes in lung squamous cell carcinoma.
    Zhou H; Zhang H; Shi M; Wang J; Huang Z; Shi J
    Int Immunopharmacol; 2020 Nov; 88():106856. PubMed ID: 32777677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Prognostic Model Based on the Immune-related Genes in Colon Adenocarcinoma.
    Sun YL; Zhang Y; Guo YC; Yang ZH; Xu YC
    Int J Med Sci; 2020; 17(13):1879-1896. PubMed ID: 32788867
    [No Abstract]   [Full Text] [Related]  

  • 4. Identification of a Prognostic Model Based on Immune-Related Genes of Lung Squamous Cell Carcinoma.
    Li R; Liu X; Zhou XJ; Chen X; Li JP; Yin YH; Qu YQ
    Front Oncol; 2020; 10():1588. PubMed ID: 33014809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prognostic model of non small cell lung cancer based on TCGA and ImmPort databases.
    Yang D; Ma X; Song P
    Sci Rep; 2022 Jan; 12(1):437. PubMed ID: 35013450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analysis of a new immune-related prognostic signature for esophageal cancer and its correlation with infiltrating immune cells and target genes.
    Peng Z; Liu XY; Cheng Z; Kai W; Song Z
    Ann Transl Med; 2021 Oct; 9(20):1576. PubMed ID: 34790782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of immune-related genes as prognostic factors in bladder cancer.
    Zhu J; Wang H; Ma T; He Y; Shen M; Song W; Wang JJ; Shi JP; Wu MY; Liu C; Wang WJ; Huang YQ
    Sci Rep; 2020 Nov; 10(1):19695. PubMed ID: 33184436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of an immune-related gene prognostic model for head and neck tumors.
    Zhou F; Chen AX; Lv HY; Liang DH; Yu HS
    J Biol Regul Homeost Agents; 2021; 35(3):975-986. PubMed ID: 34159769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of a novel immune-related prognostic model in lung squamous cell carcinoma.
    Liu Z; Wan Y; Qiu Y; Qi X; Yang M; Huang J; Zhang Q
    Int J Med Sci; 2020; 17(10):1393-1405. PubMed ID: 32624696
    [No Abstract]   [Full Text] [Related]  

  • 10. Development of a novel immune-related genes prognostic signature for osteosarcoma.
    Wu ZL; Deng YJ; Zhang GZ; Ren EH; Yuan WH; Xie QQ
    Sci Rep; 2020 Oct; 10(1):18402. PubMed ID: 33110201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction and validation of a robust prognostic model based on immune features in sepsis.
    Zheng Y; Liu B; Deng X; Chen Y; Huang Y; Zhang Y; Xu Y; Sang L; Liu X; Li Y
    Front Immunol; 2022; 13():994295. PubMed ID: 36532037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and validation of the prognostic value of immune-related genes in non-small cell lung cancer.
    Li R; Liu X; Zhou XJ; Chen X; Li JP; Yin YH; Qu YQ
    Am J Transl Res; 2020; 12(9):5844-5865. PubMed ID: 33042464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A robust six-gene prognostic signature for prediction of both disease-free and overall survival in non-small cell lung cancer.
    Zuo S; Wei M; Zhang H; Chen A; Wu J; Wei J; Dong J
    J Transl Med; 2019 May; 17(1):152. PubMed ID: 31088477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and Validation of a Tumor Microenvironment-Related Gene Signature for Prognostic Prediction in Advanced-Stage Non-Small-Cell Lung Cancer.
    Zhang X; Shi X; Zhao H; Jia X; Yang Y
    Biomed Res Int; 2021; 2021():8864436. PubMed ID: 33860055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of an Individualized Immune-Related Prognostic Risk Score in Lung Squamous Cell Cancer.
    Zhuang Y; Li S; Liu C; Li G
    Front Oncol; 2021; 11():546455. PubMed ID: 33747902
    [No Abstract]   [Full Text] [Related]  

  • 16. A novel immune-related gene signature predicts survival in esophageal squamous cell carcinoma.
    Xu T; Dai T; Zeng P; Guo Y; He K
    Transl Cancer Res; 2021 May; 10(5):2354-2367. PubMed ID: 35116551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer.
    Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X
    BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non-Small Cell Lung Cancer.
    Li B; Cui Y; Diehn M; Li R
    JAMA Oncol; 2017 Nov; 3(11):1529-1537. PubMed ID: 28687838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and verification of a hypoxia- and immune-associated prognosis signature for esophageal squamous cell carcinoma.
    Lian L; Teng SB; Xia YY; Shen XM; Zheng Y; Han SG; Wang WJ; Xu XF; Zhou C
    J Gastrointest Oncol; 2022 Apr; 13(2):462-477. PubMed ID: 35557566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction of a Novel Immune-Related mRNA Signature to Predict the Prognosis and Immune Characteristics of Human Colorectal Cancer.
    Li J; Han T; Wang X; Wang Y; Chen X; Chen W; Yang Q
    Front Genet; 2022; 13():851373. PubMed ID: 35401707
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.